Evidence map›Paper›PMID 28105461›Full record

ReviewCellular and molecular gastroenterology and hepatology2016

The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.

Masatake Tanaka, Yasuko Iwakiri

Open access · goldAbstract readReview
In one paragraph

Review in Cellular and molecular gastroenterology and hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 135 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. [The lymphatic system-an interdisciplinary challenge].Radiologie (Heidelberg, Germany) · 2025
    Review
  17. Diagnosis and Treatment of Postoperative Hepatic Lymphorrhea.Interventional radiology (Higashimatsuyama-shi (Japan) · 2025
    Review
  18. Platelet activation relieves liver portal hypertensionWorld journal of gastroenterology · 2025
    Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Masatake TanakaSection of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Yasuko IwakiriSection of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Arterial Remodeling in Chronic Liver DiseasesR01DK082600 · NIDDK · YALE UNIVERSITY · PI IWAKIRI, YASUKO · 2009 to 2014
$2.0M
Alcohol metabolism in liver sinusoidal endothelial cellsR21AA023599 · NIAAA · YALE UNIVERSITY · PI IWAKIRI, YASUKO · 2015 to 2016
$437k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS R21 AA023599NIDDK NIH HHS R01 DK082600
6 · The paper itself

Abstract

The lymphatic vascular system has been minimally explored in the liver despite its essential functions including maintenance of tissue fluid homeostasis. The discovery of specific markers for lymphatic endothelial cells has advanced the study of lymphatics by methods including imaging, cell isolation, and transgenic animal models and has resulted in rapid progress in lymphatic vascular research during the last decade. These studies have yielded concrete evidence that lymphatic vessel dysfunction plays an important role in the pathogenesis of many diseases. This article reviews the current knowledge of the structure, function, and markers of the hepatic lymphatic vascular system as well as factors associated with hepatic lymphangiogenesis and compares liver lymphatics with those in other tissues.

Indexed as

CCl4, carbon tetrachlorideCirrhosisEHE, epithelioid hemangioendotheliomaHA, hyaluronanHBx Ag, hepatitis B x antigenHCC, hepatocellular carcinomaIFN, interferonIL, interleukinInflammationLSEC, liver sinusoidal endothelial cellLyEC, lymphatic endothelial cellLYVE-1, lymphatic vessel endothelial hyaluronan receptor 1mTOR, mammalian target of rapamycinNO, nitric oxidePortal HypertensionProx1, prospero homeobox protein 1VEGFVEGFR, vascular endothelial growth factor receptorVEGF, vascular endothelial growth factor

Identifiers

PMID28105461
PMCPMC5240041
OpenAlexW2520442633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.